138 related articles for article (PubMed ID: 9272559)
1. Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.
Pica-Mattoccia L; Novi A; Cioli D
Parasitol Res; 1997; 83(7):687-9. PubMed ID: 9272559
[TBL] [Abstract][Full Text] [Related]
2. Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
Rugel AR; Guzman MA; Taylor AB; Chevalier FD; Tarpley RS; McHardy SF; Cao X; Holloway SP; Anderson TJC; Hart PJ; LoVerde PT
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():8-15. PubMed ID: 32315953
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.
Buchter V; Hess J; Gasser G; Keiser J
Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for hycanthone drug action in schistosome parasites.
Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
Pica-Mattoccia L; Cioli D
Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
[TBL] [Abstract][Full Text] [Related]
6. Studies on some derivatives of oxamniquine.
el-Hamouly W; Pica-Mattoccia L; Cioli D; Schwartz HM; Archer S
J Med Chem; 1988 Aug; 31(8):1629-31. PubMed ID: 3398000
[TBL] [Abstract][Full Text] [Related]
7. Binding of oxamniquine to the DNA of schistosomes.
Pica-Mattoccia L; Cioli D; Archer S
Trans R Soc Trop Med Hyg; 1989; 83(3):373-6. PubMed ID: 2617584
[TBL] [Abstract][Full Text] [Related]
8. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
[TBL] [Abstract][Full Text] [Related]
9. Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.
Pica-Mattoccia L; Dias LC; Moroni R; Cioli D
Exp Parasitol; 1993 Dec; 77(4):445-9. PubMed ID: 8253157
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene.
Cioli D; Pica-Mattoccia L; Moroni R
Exp Parasitol; 1992 Dec; 75(4):425-32. PubMed ID: 1493874
[TBL] [Abstract][Full Text] [Related]
11. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
[TBL] [Abstract][Full Text] [Related]
12. [A human strain of Schistosoma mansoni resistant to schistosomicides].
Dias LC; Pedro RJ; Rigo E; Goto MM; Mafra GL
Rev Saude Publica; 1978 Mar; 12(1):110. PubMed ID: 675134
[No Abstract] [Full Text] [Related]
13. [Genetic and molecular aspects of drug resistance in Schistosoma mansoni].
Pica L; Cioli D
Ann Ist Super Sanita; 1986; 22(1):153-5. PubMed ID: 3752792
[No Abstract] [Full Text] [Related]
14. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
Dias LC; Olivier CE
Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
[No Abstract] [Full Text] [Related]
15. Schistosoma mansoni: chemotherapy of infections of different ages.
Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
[TBL] [Abstract][Full Text] [Related]
16. Experimentally produced resistance of Schistosoma mansoni to hycanthone.
Jansma WB; Rogers SH; Liu CL; Bueding E
Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):926-36. PubMed ID: 907054
[TBL] [Abstract][Full Text] [Related]
17. Oxamniquine in the treatment of various schistosome infections in South Africa.
Pitchford RJ; Lewis M
S Afr Med J; 1978 Apr; 53(17):677-80. PubMed ID: 354047
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.
Wong LJ; Tsao GC; Bruce JI; Wong SS
Experientia; 1990 May; 46(5):461-4. PubMed ID: 1693342
[TBL] [Abstract][Full Text] [Related]
19. Fatal hepatic necrosis in association with hycanthone.
Hatchuel W
S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
[No Abstract] [Full Text] [Related]
20. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]